BlossomHill counsel owns 106,712 common shares
BlossomHill Therapeutics, Inc. (BLSM) reported the initial equity holdings of General Counsel Vincent Paul Liptak.
Rhea-AI Filing Summary
BlossomHill Therapeutics, Inc. (BLSM) reported the initial equity holdings of General Counsel Vincent Paul Liptak. He holds 106,712 shares of Common Stock directly and an indirect position in Series B Preferred Stock through the Walter T. Liptak Revocable Trust, convertible into 22,687 shares of Common Stock upon the closing of the company’s initial public offering, with no expiration date. Liptak is a co-beneficiary and co-trustee of the trust and has voting and dispositive power over the trust-held securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Liptak Vincent Paul
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series B Preferred Stock F1, F2 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Series B Preferred Stock — 22,687 contracts (Indirect, By Walter T. Liptak Revocable Trust);
Common Stock — 106,712 shares (Direct)
Footnotes (2)
- F1. Each share of Series B Preferred Stock (the "Preferred Stock") is convertible into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock has no expiration date.
- F2. The Reporting Person is a co-beneficiary and co-trustee of the Walter T. Liptak Revocable Trust (the "Trust") and has voting and dispositive power over the securities held by the Trust.
Key Figures
Direct Common Stock holdings: 106,712 shares
Indirect Series B Preferred underlying shares: 22,687 shares
Series B Preferred conversion ratio: 1 share of Common Stock per share of Series B Preferred Stock
3 metrics
Direct Common Stock holdings
106,712 shares
Common Stock held directly by Vincent Paul Liptak following the reported holdings
Indirect Series B Preferred underlying shares
22,687 shares
Common Stock underlying Series B Preferred Stock held indirectly via revocable trust
Series B Preferred conversion ratio
1 share of Common Stock per share of Series B Preferred Stock
Conversion upon closing of BlossomHill Therapeutics’ initial public offering
Key Terms
Series B Preferred Stock, Revocable Trust, dispositive power
3 terms
Series B Preferred Stock financial
"Each share of Series B Preferred Stock is convertible into 1 share of Common Stock"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
Revocable Trust financial
"The Reporting Person is a co-beneficiary and co-trustee of the Walter T. Liptak Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
dispositive power financial
"has voting and dispositive power over the securities held by the Trust"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider ownership did BLSM disclose for General Counsel Vincent Paul Liptak on this Form 3?
BlossomHill Therapeutics disclosed that Vincent Paul Liptak holds 106,712 shares of Common Stock directly and Series B Preferred Stock indirectly, convertible into 22,687 Common shares through a revocable trust, over which he has voting and dispositive power.
What is the conversion feature of BLSM’s Series B Preferred Stock reported by Vincent Paul Liptak?
Each share of Series B Preferred Stock is convertible into 1 share of Common Stock upon the closing of BlossomHill Therapeutics’ initial public offering, without additional consideration. The preferred stock has no expiration date on this conversion right.
AI-generated analysis. How Rhea-AI works. Not financial advice.
